Physician profile
Ali Azim
NPI 1780035030
$2,893.63
in general payments reported to CMS, 2019-2025
24 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.92 · 2021: $22.08 · 2022: $323 · 2023: $1,236 · 2024: $480 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637 · Travel and Lodging: $878 · Education: $5.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,636.64 |
| Travel and Lodging | $877.77 |
| Education | $5.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $925.59 | 2023-2024 | Da Vinci Surgical System |
| Actelion Pharmaceuticals US, INC. | $456.70 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Glaxosmithkline, LLC. | $442.42 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Insmed, INC. | $178.88 | 2024-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.29 | 2022-2025 | Ofev |
| Astrazeneca Pharmaceuticals Lp | $119.58 | 2021-2025 | Airsupra, Breztri, Andexxa |
| Genzyme Corporation | $103.08 | 2022-2025 | |
| Olympus America INC. | $69.40 | 2025 | |
| Gilead Sciences, INC. | $63.27 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $53.89 | 2025 | |
| United Therapeutics Corporation | $47.66 | 2022 | |
| Electromed, INC. | $41.26 | 2025 | Smartvest |
| Pulmonx Corporation | $38.00 | 2024 | Zephyr Endobronchial Valve |
| Bayer Healthcare Pharmaceuticals INC. | $33.06 | 2023-2024 | |
| Janssen Biotech, INC. | $25.72 | 2025 | Akeega, Balversa, Erleada |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $21.87 | 2022 | |
| Philips North America LLC | $21.32 | 2025 | Reusable Vest |
| Amgen INC. | $18.77 | 2022 | |
| Inspire Medical Systems, INC. | $18.03 | 2025 | Inspire |
| Verona Pharma, INC. | $16.80 | 2025 | Ohtuvayre |
| Vifor Pharma, INC. | $15.04 | 2024 | Zemaira |
| Merck Sharp & Dohme LLC | $14.49 | 2023 | |
| Jazz Pharmaceuticals INC. | $14.44 | 2023 | Xywav |
| Horizon Therapeutics Plc | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Azim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.